Tecnandina’s Ecuador Facility Receives ANVISA Certification

News
Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-10-07-2015
Volume 11
Issue 10

The Grünenthal Group’s Tecnandina manufacturing plant in Ecuador has received the country’s first certification from the Regulatory Authority of Brazil.

The Grünenthal Group announced on Oct. 1, 2015 that its Tecnandina manufacturing plant in Ecuador has received certification from the Regulatory Authority of Brazil (ANVISA), making it the first production plant in Ecuador to receive ANVISA certification. The certification will allow the company to export pharmaceutical products to Brazil.

Tecnandina SA belongs to the Grünenthal Group, a research-based, pharmaceutical company headquartered in Aachen, Germany.taht offers contract manufacturing from five independent production plants throughout Europe and Latin America. The company manufactures and exports to 17 countries in Central and South America, Switzerland, and the Andean countries.

Source: Grünenthal Group

 

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content